New study warns about multitasking

Mar 26, 2007

Several reports published in the United States are highlighting the limits of multitasking in the office and beyond.

The New York Times reported on the recent findings, gleaned from numerous studies conducted by neuroscientists, psychologists and management professors, who suggest that people should slow down on their multitasking when working in an office, studying or driving a car.

Some researchers said driving is the most dangerous time to multitask, as a one-second delay could be fatal.

Rene Marois, a neuroscientist and director of the Human Information Processing Laboratory at Vanderbilt University, told the Times that one of the problems is that people tend to think the brain can handle more than it really can at one time.

Multitasking is believed to be especially prevalent among teenagers and young workers in their 20s who are overall most adept to the latest technology.

Copyright 2007 by United Press International

Explore further: Allergan to cut 1,500 employees in restructuring (Update)

add to favorites email to friend print save as pdf

Related Stories

The perils of texting while driving

Oct 11, 2013

US research reveals that 4 out of 5 college student drivers have used their cell phones to send or receive text messages while driving despite the majority recognizing that the activity represents a risk. Garold Lantz and ...

Review: Surface mostly bridges work-play divide

Nov 02, 2012

I've been conditioned just like any other consumer to expect certain things from certain companies. When it comes to tablets, I expect Apple's to look and feel amazing, Google's to seamlessly blend online ...

Recommended for you

British Lords hold ten-hour debate on assisted dying

Jul 19, 2014

Members of Britain's unelected House of Lords spent almost ten hours on Friday discussing whether to legalise assisted dying, in an often emotional debate putting the question back on the agenda, if not on the statute books.

AbbVie, Shire agree on $55B combination

Jul 18, 2014

The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.

Safety problems at US germ labs acknowledged

Jul 16, 2014

(AP)—The director of the U.S. Centers for Disease Control and Prevention acknowledged Wednesday that systemic safety problems have for years plagued federal public health laboratories that handle dangerous ...

User comments : 0